Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Enorama Pharma AB is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is handled by 1 distinct examiner, YOUNG, MICAH PAUL, who is responsible for 1 busiest examiner pending action. The portfolio's current USPTO presence is limited to 1 distinct art unit, indicating a highly specific technical focus for the pending matter. With only 1 pending office action, the company's current legal efforts are concentrated on a single set of claims.
The fact that YOUNG, MICAH PAUL is the only examiner involved means that the prosecution outcome depends entirely on this individual's interpretation of the Biotechnology & Pharmaceuticals field. This 1 distinct art unit environment suggests that the company is not currently seeking broad protection across multiple technological disciplines at the USPTO. Practitioners can focus their resources on the specific examination style of the 1 distinct examiner. This singular focus on 1 busiest examiner pending action allows for a direct and efficient response to the current office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOUNG, MICAH PAUL | 1 | 55.1% | +30.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17761918 | NICOTINE POUCH | YOUNG, MICAH PAUL | 34d |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17761918 | NICOTINE POUCH | YOUNG, MICAH PAUL | 1618 | §103 | Non-Final OA | 34d | Pending | Mar 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial